174 related articles for article (PubMed ID: 37452404)
1. Delineation of the phenotypes and genotypes of facial infiltrating lipomatosis associated with PIK3CA mutations.
Chen H; Sun B; Gao W; Qiu Y; Hua C; Lin X
Orphanet J Rare Dis; 2023 Jul; 18(1):189. PubMed ID: 37452404
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA activating mutations in facial infiltrating lipomatosis.
Maclellan RA; Luks VL; Vivero MP; Mulliken JB; Zurakowski D; Padwa BL; Warman ML; Greene AK; Kurek KC
Plast Reconstr Surg; 2014 Jan; 133(1):12e-19e. PubMed ID: 24374682
[TBL] [Abstract][Full Text] [Related]
3. PIK3CA mutations in lipomatosis of nerve with or without nerve territory overgrowth.
Blackburn PR; Milosevic D; Marek T; Folpe AL; Howe BM; Spinner RJ; Carter JM
Mod Pathol; 2020 Mar; 33(3):420-430. PubMed ID: 31481664
[TBL] [Abstract][Full Text] [Related]
4. Somatic PIK3CA mutations are present in multiple tissues of facial infiltrating lipomatosis.
Couto JA; Konczyk DJ; Vivero MP; Kozakewich HPW; Upton J; Fu X; Padwa BL; Mulliken JB; Warman ML; Greene AK
Pediatr Res; 2017 Nov; 82(5):850-854. PubMed ID: 28665924
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and surgical management of facial infiltrating lipomatosis: a single center experience.
Chen H; Sun B; Xia W; Qiu Y; Gao W; Hua C; Lin X
Head Face Med; 2024 Feb; 20(1):13. PubMed ID: 38378686
[TBL] [Abstract][Full Text] [Related]
6. [
Wu JH; Tian W; Tian GL; Tian MM; Chen SL; Tian W
Zhonghua Wai Ke Za Zhi; 2018 Jul; 56(7):538-542. PubMed ID: 30032537
[No Abstract] [Full Text] [Related]
7. Phenotypic and genetic spectrum of isolated macrodactyly: somatic mosaicism of PIK3CA and AKT1 oncogenic variants.
Tian W; Huang Y; Sun L; Guo Y; Zhao S; Lin M; Dong X; Zhong W; Yin Y; Chen Z; Zhang N; Zhang Y; Wang L; Lin J; Yan Z; Yang X; Zhao J; Qiu G; Zhang J; Wu Z; Wu N;
Orphanet J Rare Dis; 2020 Oct; 15(1):288. PubMed ID: 33054853
[TBL] [Abstract][Full Text] [Related]
8. Facial infiltrating lipomatosis with hemimegalencephaly and lymphatic malformations caused by nonhotspot phosphatidylinositol 3-kinase catalytic subunit alpha mutation.
Chen H; Sun B; Gao W; Jia H; Zhou L; Hua C; Lin X
Pediatr Dermatol; 2023; 40(6):1115-1119. PubMed ID: 37190882
[TBL] [Abstract][Full Text] [Related]
9. An investigation of PIK3CA mutations in isolated macrodactyly.
Wu J; Tian W; Tian G; Sumner K; Hutchinson DT; Ji Y
J Hand Surg Eur Vol; 2018 Sep; 43(7):756-760. PubMed ID: 29661094
[TBL] [Abstract][Full Text] [Related]
10. Congenital infiltrating lipomatosis of the face with lingual mucosal neuromas associated with a PIK3CA mutation.
Briand C; Galmiche-Rolland L; Vabres P; Couloigner V; Audebert S; Misery L; Abasq-Thomas C
Pediatr Dermatol; 2020 Nov; 37(6):1128-1130. PubMed ID: 32770747
[TBL] [Abstract][Full Text] [Related]
11. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum.
Keppler-Noreuil KM; Sapp JC; Lindhurst MJ; Parker VE; Blumhorst C; Darling T; Tosi LL; Huson SM; Whitehouse RW; Jakkula E; Grant I; Balasubramanian M; Chandler KE; Fraser JL; Gucev Z; Crow YJ; Brennan LM; Clark R; Sellars EA; Pena LD; Krishnamurty V; Shuen A; Braverman N; Cunningham ML; Sutton VR; Tasic V; Graham JM; Geer J; Henderson A; Semple RK; Biesecker LG
Am J Med Genet A; 2014 Jul; 164A(7):1713-33. PubMed ID: 24782230
[TBL] [Abstract][Full Text] [Related]
12. Somatic mosaicism for the p.His1047Arg mutation in PIK3CA in a girl with mesenteric lipomatosis.
Cohen AS; Townsend KN; Xiang QS; Attariwala R; Borchers C; Senger C; Picker W; Levi J; Yewchuk L; Tan J; Eydoux P; Lum A; Yong SL; McKinnon ML; Lear SA; Everett R; Jones SJ; Yip S; Gibson WT
Am J Med Genet A; 2014 Sep; 164A(9):2360-4. PubMed ID: 24903541
[TBL] [Abstract][Full Text] [Related]
13. Somatic PIK3CA mutations in seven patients with PIK3CA-related overgrowth spectrum.
Yeung KS; Ip JJ; Chow CP; Kuong EY; Tam PK; Chan GC; Chung BH
Am J Med Genet A; 2017 Apr; 173(4):978-984. PubMed ID: 28328134
[TBL] [Abstract][Full Text] [Related]
14. Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth.
Wenger TL; Ganti S; Bull C; Lutsky E; Bennett JT; Zenner K; Jensen DM; Dmyterko V; Mercan E; Shivaram GM; Friedman SD; Bindschadler M; Drusin M; Perkins JN; Kong A; Bly RA; Dahl JP; Bonilla-Velez J; Perkins JA
Genet Med; 2022 Nov; 24(11):2318-2328. PubMed ID: 36066547
[TBL] [Abstract][Full Text] [Related]
15. [PIK3CA-related overgrowth syndrome (PROS)].
Venot Q; Canaud G
Nephrol Ther; 2017 Apr; 13 Suppl 1():S155-S156. PubMed ID: 28577738
[TBL] [Abstract][Full Text] [Related]
16. Activating PIK3CA mutation promotes adipogenesis of adipose-derived stem cells in macrodactyly via up-regulation of E2F1.
Sun B; Jiang Y; Cui H; Fang X; Han G; Dai X; Zhou S; Mao H; Wang B
Cell Death Dis; 2020 Jul; 11(7):600. PubMed ID: 32732866
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutation testing as a valuable molecular surrogate for lipomatosis of the median nerve: clinicopathological and molecular analysis of six cases.
Osterloh J; Agaimy A; Fried F; Stoehr R; Janka R; Arkudas A; Horch RE
Virchows Arch; 2023 Jul; 483(1):33-39. PubMed ID: 37067587
[TBL] [Abstract][Full Text] [Related]
18. In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS).
Ranieri C; Di Tommaso S; Loconte DC; Grossi V; Sanese P; Bagnulo R; Susca FC; Forte G; Peserico A; De Luisi A; Bartuli A; Selicorni A; Melis D; Lerone M; Praticò AD; Abbadessa G; Yu Y; Schwartz B; Ruggieri M; Simone C; Resta N
Neurogenetics; 2018 May; 19(2):77-91. PubMed ID: 29549527
[TBL] [Abstract][Full Text] [Related]
19. Recurrent
Oh KS; Bahmad HF; Stoyanov KV; Amjad IH; Brathwaite C
Curr Issues Mol Biol; 2023 Feb; 45(2):1712-1719. PubMed ID: 36826055
[TBL] [Abstract][Full Text] [Related]
20. PIK3CA Mutational Analysis in Patients With Macrodactyly.
Becker J; Gross UC; Weber DM; Weibel L; Theiler M; Brandt S; Bode PK
Pediatr Dev Pathol; 2022; 25(6):624-634. PubMed ID: 36314082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
